Transforming cancer detection: renovarocube introduces flamingo, a novel ai model based on fragmentomics

Los angeles and amsterdam, april 30, 2024 (globe newswire) -- renovarocube, wholly owned subsidiary of renovaro, inc. (nasdaq: renb), a company at the forefront of ai-driven healthcare innovation, proudly unveils flamingo, a potentially groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. leveraging ultra-low pass whole genome sequencing (ulp-wgs) of cell-free dna (cfdna), flamingo represents a promising leap forward in the fight against cancer.
RENB Ratings Summary
RENB Quant Ranking